We discovered our drug has a serious side effect that affects maybe two percent of patients and the regulatory team is debating whether to report it immediately or wait for more data.
More people experience this than they realize.
You know your drug can hurt some patients, and the company is stalling on telling anyone.
“Where Are You with Science — Biotech & Pharmaceutical R&D?”
If this sounds familiar, the Library can help you find the bigger picture.